Table 2.
Postoperative outcomes (n = 124)
| Time to reach discharge criteria, median (IQR), days | 2 (1–3) |
| Time between discharge criteria and length of ABs treatment, median (IQR)*, days | 2 (1–4) |
| Time between discharge criteria and length of stay, median (IQR)*, days | 3 (2–4) |
| Cumulative no. of patients having met discharge criteria, n (%)* | |
| POD 1 | 56 (46) |
| POD 2 | 81 (67) |
| POD 3 | 98 (81) |
| POD 4 | 111 (92) |
| POD 5 | 117 (97) |
| >POD 5 | 121 (100) |
| Received AB duration, median (IQR), days | 5 (3; 5) |
| Received AB duration in days, n (%) | |
| 2 days | 2 (2) |
| 3 days | 34 (27) |
| 4 days | 2 (2) |
| 5 days | 64 (52) |
| >5 days | 22 (17) |
| Deviation from prescribed AB duration, n (%)** | 44 (33) |
| Reduced | 3 (2) |
| Prolonged | 40 (33) |
| Route of administration, n (%)*** | |
| IV only | 80 (65) |
| IV/oral combination (IV/PO) | 36 (29) |
| Length of stay, median (IQR), days | 5 (4; 6) |
| Any postoperative complication, n (%) | 26 (21) |
| Infectious complications, n (%) | 15 (12) |
| IAA, n (%) | 14 (11) |
| SSI, n (%) | 1 (1) |
POD, postoperative day; AB, antibiotic(s); IQR, interquartile range; IAA, intra-abdominal abscess; SSI, surgical site infection; IV, intravenous.
*
3 missing,
**
1 missing,
***
8 missing.